Rotella Capital Management, Inc. - CELL THERAPEUTICS INC ownership

CELL THERAPEUTICS INC's ticker is CTIC and the CUSIP is 150934883. A total of 66 filers reported holding CELL THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Rotella Capital Management, Inc. ownership history of CELL THERAPEUTICS INC
ValueSharesWeighting
Q3 2013$18,000
-35.7%
10,900
-59.6%
0.03%
-62.9%
Q2 2013$28,00027,0000.09%
Other shareholders
CELL THERAPEUTICS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Perceptive Advisors 13,989,346$22,676,0000.93%
First Heartland Consultants, Inc. 74,624$124,0000.08%
Geduld E E 50,000$81,0000.05%
WASHINGTON TRUST Co 346,616$562,0000.04%
Rotella Capital Management, Inc. 10,900$18,0000.03%
ZACKS INVESTMENT MANAGEMENT 201,575$327,0000.01%
Jane Street Holding, LLC 488,727$792,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 268,978$436,0000.01%
BENJAMIN F. EDWARDS & COMPANY, INC. 10,900$18,0000.01%
UNITED CAPITAL FINANCIAL ADVISORS, LLC 132,236$214,0000.01%
View complete list of CELL THERAPEUTICS INC shareholders